The DOI matches its Crossref record.
Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability: The Atherosclerosis Risk in Communities Study
Abstract
OBJECTIVE: To test at the population level whether people with multiple metabolic syndrome (MMS) disorders have reduced cardiac autonomic activity (CAA). RESEARCH DESIGN AND METHODS: We examined the association between the level of CAA and MMS disorders, at the degree of clustering and the segregate combination levels, using a random sample of 2,359 men and women aged 45–64 years from the biracial, population-based Atherosclerosis Risk in Communities (AR1C) Study. Supine resting 2-min beat-to-beat heart rate data were collected. High-frequency (HF) (0.15–0.35 Hz) and low-frequency (LF) (0.025–0.15 Hz) spectral powers, the ratio of LF to HF, and the SD of all normal R-R intervals (SDNN) were used as the conventional indices of heart rate variability (HRV) to measure CAA. The MMS disorders included hypertension, type 2 diabetes, and dyslipidemia. RESULTS: HRV indices were significantly lower in individuals with MMS disorders. The multivariable adjusted mean HF was 0.85 (beat/min)2 in subjects with all three MMS disorders, in contrast to 1.31 beat/min)2 in subjects without any MMS disorder. At the segregated combination level, the multivariable adjusted means ± SEM of HF were 1.34 ± 0.05, 1.16 ± 0.05, 1.01 ± 0.17, and 1.34 ± 0.05 (beat/min)2, respectively, for subjects without any MMS disorder, with hypertension only, with diabetes only, and with dyslipidemia only, and the means ± SEM of HF were 0.93 ± 0.04,0.70 ± 0.15, and 1.20 ± 0.05 eat/min)2, respectively, for subjects with diabetes and hypertension, diabetes and dyslipidemia, and hypertension and dyslipidemia. An increase in fasting insulin of 1 SD was associated with 88% higher odds of having a lower HF The pattern of associations was similar for LF and SDNN. CONCLUSIONS: These findings suggest that MMS disorders adversely affect cardiac autonomic control and a reduced cardiac autonomic control may contribute to the increased risk of subsequent cardiovascular events in individuals who exhibit MMS disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, indices such as heart rate variability 27,28 and urinary normetanephrine 28 have suggested an increased sympathetic drive and its effects in MS patients.”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [28]
Citations
Cited by
Sorted by citations
Items 101–200 of 223
Short-Term Heart Rate Variability in Metabolic Syndrome: A Systematic Review and Meta-Analysis
Guzmán, J. E. O., Mollà‐Casanova, S., Serra‐Añó, P., Arias-Mutis, O. J., Calvo, C. J., Bizy, A., Alberola, A. M., Chorro, F. J., & Zarzoso, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186051 · Cited by 31
“The MA showed that SDNN is decreased in patients with MS, which was previously described by most studies [10,18,32,34,36,37], thus clearly altering cardiac autonomic control in patients with MS.”
ResultYufu, K., Takahashi, N., Okada, N., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1122 · Cited by 21
Anan, F., Masaki, T., Iwao, T., Eto, T., Shimomura, T., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802061818 · Cited by 21
Hu, M. X., Lamers, F., Hiles, S. A., Penninx, B. W. J. H., & de Geus, E. J. C. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.018 · Cited by 21
“…are largely in line with literature linking basal autonomic dysregulation to MetS (Brunner et al., 2002; Grassi et al., 2015, 2005; Koskinen et al., 2009; Liao et al., 1998; Min et al., 2008; Stein et al., 2007; Vrijkotte et al., 2015) and MetS components (Kimura et al., 2006; Ljung et al., 2000).”
Influentialde Faria, C. A., Moraes, R. S., Filho, D. C. S., et al. (2009) · EP Europace · doi:10.1093/europace/eup095 · Cited by 20
The Cardiometabolic Syndrome and Cardiovascular Disease
Ash‐Bernal, R., & Peterson, L. R. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.0197-3118.2006.05452.x · Cited by 21
Heart rate variability analysed by Poincaré plot in patients with metabolic syndrome
Kubičková, A., Kozumplík, J., Nováková, Z., et al. (2015) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2015.11.004 · Cited by 20
“Three of the studies [2,3,7] used SDRR on differently long recordings.”
MethodCan Heart Rate Variability be used to Estimate Gas Exchange Threshold in Obese Adolescents?
Vasconcellos, F. V. D. A., Seabra, A., Montenegro, R. A., et al. (2015) · International Journal of Sports Medicine · doi:10.1055/s-0034-1398654 · Cited by 20
Yufu, K., Takahashi, N., Okada, N., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0905 · Cited by 19
Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients
Shimomura, T., Anan, F., Masaki, T., Umeno, Y., Eshima, N., Saikawa, T., Yoshimatsu, H., Fujiki, M., & Kobayashi, H. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02464.x · Cited by 19
Endukuru, C., Gaur, G., Yerrabelli, D., Sahoo, J., & Vairappan, B. (2020) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2020.10.018 · Cited by 18
Anan, F., Masaki, T., Kikuchi, H., Iwao, T., Shimomura, T., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.017 · Cited by 19
“[15] D.”
BackgroundKuch, B., Parvanov, T., Hense, H. W., Axmann, J., & Bolte, H. D. (2004) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2004.92523.x · Cited by 18
Yufu, K., Okada, N., Ebata, Y., et al. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.12.009 · Cited by 18
Anan, F., Takahashi, N., Shimomura, T., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2005.12.007 · Cited by 18
Fujibayashi, M., Hamada, T., Matsumoto, T., Kiyohara, N., Tanaka, S., Kotani, K., Egawa, K., Kitagawa, Y., Kiso, Y., Sakane, N., et al. (2009) · American Journal of Human Biology · doi:10.1002/ajhb.20899 · Cited by 18
Role of Reduced Heart Rate Volatility in Predicting Death in Trauma Patients
Morris, J. A., & Norris, P. R. (2005) · Advances in Surgery · doi:10.1016/j.yasu.2005.04.004 · Cited by 18
Nevels, T. L., Wirth, M. D., Ginsberg, J. P., McLain, A. C., & Burch, J. B. (2023) · SLEEP · doi:10.1093/sleep/zsad013 · Cited by 19
“HRV indices were lower in individuals with multiple components of metabolic syndrome, and HRV decreased as the number of individual metabolic components achieving criterion values increased [36].”
BackgroundDevelopment of autonomic dysfunction with intermittent hypoxia in a lean murine model
Chalacheva, P., Thum, J. A., Yokoe, T., O'Donnell, C. P., & Khoo, M. C. K. (2013) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2013.06.002 · Cited by 16
Heart rate variability and intima media thickness
Eller, N. H., Malmberg, B., & Bruhn, P. J. (2006) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1303_3 · Cited by 16
“HRV has several times been shown to be negatively correlated to increased risk of illness and death (Dekker et al., 2000; Liao et al., 2002; Liao et al., 1998).”
BackgroundDegertekin, M. M. (2014) · Medical Science Monitor · doi:10.12659/msm.890741 · Cited by 16
“The components of metabolic syndrome perform sympathetic activation [11], and several studies have demonstrated the association between metabolic syndrome and decreased heart rate variability [12,13].”
BackgroundUchida, E., Anan, F., Masaki, T., Kaneda, K., Nawata, T., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02538.x · Cited by 15
Dijkstra, M. W. M. C. S., Soer, R., Bieleman, A., McCraty, R., Oosterveld, F. G. J., Gross, D. P., & Reneman, M. F. (2018) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-018-9422-4 · Cited by 16
“Low HRV is indicated as a predictor for metabolic syndrome and cardiovascular diseases (Dekker et al. 2000; Liao et al. 1998; Licht et al. 2013; Thayer and Lane 2007; Tsuji et al. 1996; Wulsin et al. 2016).”
BackgroundMethodResultVisceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes
Murakami, D., Anan, F., Masaki, T., Umeno, Y., Shigenaga, T., Eshima, N., & Nakagawa, T. (2019) · Journal of Diabetes Research · doi:10.1155/2019/3129286 · Cited by 13
“Dyslipidemia was defined as a fasting triglyceride level of ≥200 mg/dl or HDL-C concentration of <45 mg/dl for women and <35 mg/dl for men [18].”
BackgroundShimomura, T., Anan, F., Umeno, Y., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02062.x · Cited by 15
“Essential hypertension was defined as diastolic blood pressure ‡90 mmHg, systolic blood pressure ‡140 mmHg, or self-reported use of antihypertensive medication [14].”
BackgroundEtiology of the Metabolic Syndrome
Fan, A. Z. (2007) · Current Cardiology Reviews · doi:10.2174/157340307782418389 · Cited by 14
Anan, F., Masaki, T., Umeno, Y., Iwao, T., Yonemochi, H., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.013 · Cited by 14
Romero‐Martínez, Á., Lila, M., & Moya‐Albiol, L. (2021) · Journal of Interpersonal Violence · doi:10.1177/0886260520985494 · Cited by 14
“In fact, we considered it particularly important to include age, body mass index (BMI), and drug misuse in our study because they are relevant to HRV and other cardiorespiratory variables (Benichou et al., 2018; Khoo et al., 2000; Liao et al., 1998; Vasconcelos & Junqueira, 2012; Vitoria-Estruch et al., 2018).”
BackgroundAnan, F., Masaki, T., Yonemochi, H., Takahashi, N., Nakagawa, M., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0421-6 · Cited by 14
“Consistent with the present results, a previous study demonstrated that cardiac diastolic dysfunction is associated with cardiovascular autonomic dysfunction and insulin resistance [19].”
InfluentialSíndrome metabólico, resistencia a la insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg?
Costa, B., Cabré, J. J., & Martín‐Luján, F. (2003) · Atención Primaria · doi:10.1016/s0212-6567(03)79204-x · Cited by 14
John, A. P., Udupa, K., Avangapur, S., Sujan, M. U., Inbaraj, G., Vasuki, P. P., Mahadevan, A., Anilkumar, R., Shekar, M. A., & Sathyaprabha, T. N. (2022) · PubMed Central · Cited by 13
Anan, F., Masaki, T., Umeno, Y., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0388 · Cited by 12
Balcıoğlu, A. S., Akıncı, S., Çiçek, D., Eldem, H. O., Çoner, A., Bal, U. A., & Müderrisoğlu, H. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.09.001 · Cited by 12
Effect of Meditation on Endothelial Function in Black Americans With Metabolic Syndrome
Vaccarino, V., Kondwani, K., Kelley, M. E., Murrah, N. V., Boyd, L., Ahmed, Y. A., Meng, Y. X., Gibbons, G. H., Hooper, W. C., Staercke, C. D., et al. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31829ac4f4 · Cited by 12
“Several, if not all, of the metabolic syndrome risk factors,(53-55) as well as visceral fat and insulin resistance,(56,57) have been linked to adrenocortical and autonomic disturbances.”
BackgroundShinohara, T. (2012) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000209 · Cited by 10
“Essential hypertension was defined as diastolic blood pressure (BP) ≥90 mmHg, systolic BP ≥140 mmHg or self-reported use of anti-hypertensive medication [10].”
BackgroundVrachimis, A., Hadjicharalambous, M., & Tyler, C. J. (2016) · Health · doi:10.4236/health.2016.82017 · Cited by 11
“One non-invasive clinical predictor of CVD morbidity and mortality is heart rate variability (HRV) [2]-[4].”
BackgroundCo-Existence of hypertension worsens post-exercise cardiac autonomic recovery in type 2 diabetes
Verma, S., Bhati, P., Ahmad, I., Masroor, S., Ali, K., Singla, D., & Hussain, M. E. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.06.007 · Cited by 11
Chamarthi, B., Vinik, A. I., Ezrokhi, M., & Cincotta, A. H. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.101 · Cited by 10
Role of interleukin-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients
Shinohara, T., Takahashi, N., Yufu, K., Anan, F., Kakuma, T., Hara, M., Nakagawa, M., Saikawa, T., & Yoshimatsu, H. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0809-y · Cited by 11
Prediction of hypotension in spinal anesthesia
Park, S.-S. (2013) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2013.65.4.291 · Cited by 11
“[9] showed lower HRV, including the low-frequency (LF) and high-frequency (HF) components, in patients with hypertension, excluding the LF/HF ratio.”
BackgroundTuck, N. L., Adams, K. S., & Consedine, N. S. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12242 · Cited by 11
“…identified as a risk factor for poorer health outcomes, including immune dysfunction, inflammation (Lampert et al., 2008), the metabolic syndrome (Liao et al., 1998; Stein et al., 2007), ischaemic heart disease heart failure (Dekker et al., 2000), and diabetes (for reviews, see Kemp & Quintana,…”
BackgroundHuang, W., Liu, W., Chen, T., Chen, W., & Huang, W. (2020) · Asia-Pacific Psychiatry · doi:10.1111/appy.12392 · Cited by 10
Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients
Fukunaga, N., Anan, F., Kaneda, K., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.033 · Cited by 10
Gentile, C., Ditto, B., Deschamps, A., & D’Antono, B. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kay063 · Cited by 10
FABP3, FABP4, and heart rate variability among patients with chronic schizophrenia
Hung, W., Yu, T., Wu, C., Lee, T., Tsai, I., Hsuan, C., Chen, C., Chung, F., Lee, Y., & Tang, W.-H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165621 · Cited by 9
“found that metabolic syndrome was associated with lower HRV (65).”
BackgroundZillner, L., Andreas, M., & Mach, M. (2024) · mHealth · doi:10.21037/mhealth-23-19 · Cited by 15
Anan, F., Yonemochi, H., Masaki, T., Takahashi, N., Nakagawa, M., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0200-9 · Cited by 9
“Cardiac diastolic dysfunction is associated with cardiovascular autonomic dysfunction and insulin resistance [15].”
BackgroundBarzilay, J. I., & Stein, P. K. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0027 · Cited by 9
“In the ARIC Study, 63 multiple components of the metabolic syndrome were associated with low HRV.”
Tsubokawa, M., Nishimura, M., Tamada, Y., & Nakaji, S. (2022) · Healthcare · doi:10.3390/healthcare10050793 · Cited by 9
“Therefore, the prevention of high TG and blood pressure in addition to high blood glucose levels may be important, as metabolic syndrome is reportedly associated with HRV reduction in both Western and Japanese populations [45,46].”
BackgroundCardiac autonomic activity in depression and anxiety: Heartfelt afflictions of the mind
Hu, X. (2019) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 9
HEART RATE VARIABILITY IN METABOLIC SYNDROME
Raimundo, R. D., & Godleski, J. J. (2015) · Journal of Human Growth and Development · doi:10.7322/jhgd.96757 · Cited by 8
Anan, F., Masaki, T., Takahashi, N., Nakagawa, M., Yonemochi, H., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.001 · Cited by 8
Anan, F., Masaki, T., Tatsukawa, H., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.008 · Cited by 8
Interplay of heart rate variability and resting heart rate on mortality in type 2 diabetes
Huang, Y., Xie, P., Zhang, S., Liu, M., Xiong, Z., Huang, R., Huang, Z., Zhong, X., Chen, Z., Zhou, Z., et al. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102930 · Cited by 7
Lee, S. H., Lee, D. H., Ha, D. H., & Oh, Y. J. (2015) · BMC Anesthesiology · doi:10.1186/s12871-015-0125-6 · Cited by 7
“Second, patients who were taking β-blockers, angiotensin receptor blockers or angiotensin-converting enzyme inhibitors [32, 33], which can affect the autonomic nervous system, were excluded from this study; however, HRV depression by hypertension itself, including the LF and HF components, may have influenced our resu…”
BackgroundChen, Y., Liu, H., Zou, J., et al. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.06.028 · Cited by 7
Macagnan, F. E., Feóli, A. M. P., & Russomano, T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0065 · Cited by 7
Reliability of the heart rate variability threshold during treadmill exercise
Hargens, T. A., Chambers, S., Luden, N. D., & Womack, C. J. (2022) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12760 · Cited by 7
“Exclusion criteria included presence of metabolic, pulmonary or cardiovascular disease and regular use of medications that alter HRV (American College of Sports Medicine et al., 2021; Liao et al., 1998; Thayer et al., 2010).”
BackgroundMethodInfluentialVéber, O. Á., Lendvai, Z., Rónai, K. Z., Dunai, A., Zoller, R., Lindner, A. V., Turányi, C. Z., Szocs, J. L., Keresztes, K., Tabák, Á. G., et al. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0111 · Cited by 7
Correlations of urinary albumin excretion and atherosclerosis in Japanese type 2 diabetic patients
Anan, F., Masaki, T., Umeno, Y., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.009 · Cited by 7
Murozono, Y., Yufu, K., Takahashi, N., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0784 · Cited by 6
Habib, S. S., Alkahtani, S. A., Aljawini, N., Habib, S. M., & Flatt, A. A. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220780 · Cited by 7
Interleukin-6 and silent cerebral infarction in hemodialysis patients: a cross-sectional study
Kikuchi, H., Anan, F., Kaneda, K., Nawata, T., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03226.x · Cited by 6
Anan, F., Masaki, T., Jikumaru, K., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02301.x · Cited by 6
Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus
Davies, J. I., & Struthers, A. D. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203020030030301 · Cited by 6
강설중, & Jung, S.-L. (2010) · Exercise Science · doi:10.15857/ksep.2010.19.3.277 · Cited by 6
Body Mass Index May Influence Heart Rate Variability
Rodrigues, T. S., & Quarto, L. J. G. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180201 · Cited by 5
Zhou, H., Huang, Y., Xie, P., Zhang, S., Liu, M., Xiong, Z., Huang, R., Xu, X., Li, M., Zhou, Z., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.035788 · Cited by 5
“34 As a result, CAN may represent a phenotype in which hyperglycemia is strongly associated with CVD and death, and subgroups with CAN would be helped by intensive glycemic control.”
Enhancement of cardiac autonomic nervous system activity by blood flow restriction in the human leg
Kiyohara, N., Kimura, T., Tanaka, T., & Moritani, T. (2006) · International Journal of KAATSU Training Research · doi:10.3806/ijktr.2.35 · Cited by 4
“Autonomic Nervous System Activity Measurement of the HRV integrates pre-synaptic and post-synaptic end-organ response and provides a comprehensive quantitative and qualitative evaluation of neuro-autonomic function under various physiological conditions and clinical settings (Davy et al. 1998; Hayano et al. 1990; Haya…”
BackgroundYamshchikova, A. V., Fleishman, A. N., Gidayatova, M. O., et al. (2019) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2019-6-359-363 · Cited by 4
Electrocardiographic Analysis of Heart Rate Variability in Aging Heart
Santillo, E., Migale, M., Fallavollita, L., Marini, L., & Balestrini, F. (2012) · InTech eBooks · doi:10.5772/22538 · Cited by 4
Kardiovaskuläre autonome diabetische Neuropathie
Ziegler, D. (2005) · Steinkopff eBooks · doi:10.1007/3-7985-1531-x_12 · Cited by 4
Significant association of insulin and proinsulin with clustering of cardiovascular risk factors
Jia, E. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i1.149 · Cited by 4
Urologist), F. I. C. M. S., & kamal, M. (2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1066673 · Cited by 4
Banu, I., Nguyen, M. T., Hamo-Tchatchouang, E., Cosson, E., & Valensi, P. E. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.04.021 · Cited by 4
The Relationship between Heart Rate Variability and Aortic Knob Width
Sung, S.-Y., Han, J. H., Kim, J. H., et al. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.18.0077 · Cited by 3
Anan, F., Masaki, T., Shinohara, T., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.01.012 · Cited by 3
Cardiac Autonomic Modulation and Sleep-Disordered Breathing in Children
Liao, D., Liu, J., Vgontzas, A. N., Rodriguez-Colon, S. M., Calhoun, S. L., Li, X., & Bixler, E. O. (2009) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2008.12.001 · Cited by 3
Self-citationAkyel, A. (2012) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2012.01826 · Cited by 3
Optimal resting heart rate in adult population: factors related to the heart rate
Cho, H. S., Shin, D. G., Bae, J. H., Sohn, J. W., Hong, G., Park, J. S., Kim, Y. J., Shim, B. S., & Kim, H. J. (2007) · The Korean Journal of Internal Medicine · Cited by 3
Kumar, E. C., Gaur, G., Yerrabelli, D., Sahoo, J., Vairappan, B., & Goud, A. (1993) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2023.27.1.49 · Cited by 4
“They revealed that MetS and its components were linked to CAD with reduced parasympathetic and increased sympathetic activity [36-38].”
BackgroundElevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease
Inoue, T., & Ohya, Y. (2011) · Current Hypertension Reviews · doi:10.2174/157340211795909034 · Cited by 3
“[60] Liao D, Sloan RP, Cascio WE, et al.”
BackgroundMora, J. A. Ó. (2018) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2018.11.00387 · Cited by 3
Mechanisms of Sudden Cardiac Death
Cascio, W. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_19 · Cited by 3
Self-citationCommentary: Heart rate and blood pressure: risk factors or risk markers?
Carnethon, M. R. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp325 · Cited by 3
Pongwattanapakin, K., Care, C., Sitticharoon, C., Wilasrusmee, K. T., Keadkraichaiwat, I., Maikaew, P., & Sririwichitchai, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-21757-1 · Cited by 3
Alteration of Heart Rate Variability in People With Bowel Preparation Before Colonoscopy
Huang, S.-C., Fang, W., Wang, C.-C., Chen, W., Kao, T., Hwang, L.-L., Chu, C., & Chang, Y. (2015) · Medicine · doi:10.1097/md.0000000000001926 · Cited by 2
“HRV is reported to be related to age,(2) gender,(3,4) obesity,(5) hypertension,(6,7) diabetes,(8,9) and hyperlipidemia.(10,11) A decreased HRV reflects an imbalance of the autonomic system and is an important predictor for poor prognosis in patients with heart disease(12,13) and in the general population(14) and in a…”
BackgroundAssociations Between Heart Rate Variability and Metabolic Syndrome Risk Factors
Stuckey, M. I. (2013) · Scholarship@Western (Western University) · Cited by 2
Cazelato, L., Rodrigues, P. H., & Quitério, R. J. (2018) · Revista de Atenção à Saúde · doi:10.13037/ras.vol16n55.4674 · Cited by 2
Heart Rate Variability as Biomarker for Prognostic of Metabolic Disease
Albarado-Ibáñez, A., Arroyo-Carmona, R. E., Sánchez, D. A. B., Limón-Cantú, M., López-Silva, B., Ita-Amador, M. L., & Torres-Jácome, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88766 · Cited by 2
Endukuru, C. K., Gaur, G. S., Yerrabelli, D., Sahoo, J., Vairappan, B., & Goud, A. C. (2023) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2022-0208 · Cited by 2
Ochieng, B., Akbulut, F. P., & Catal, C. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06185-6 · Cited by 1
“Through previous studies [10], it has been shown that middle-aged and elderly subjects are correlated with lower HRV.”
Patil, B. M., & Thippeswamy, B. S. (2007) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.32525 · Cited by 1
Heart Rate Variability Expressed by Poincaré Plot in Metabolic Syndrome
Drkošová, A., Kozumplík, J., & Nováková, Z. (2014) · Cited by 1
Novikova, D. S., Попкова, Т. В., Gerasimov, A. N., et al. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-1-18-24 · Cited by 1
Rasheed, M. K., Rasheed, M. K., & Mahmood, H. G. (2013) · International Journal of Drug Development and Research · Cited by 1
Провоторов, В. М., & Gluhovsky, M. L. (2009) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2009-5-6-29-34 · Cited by 1
“…показана связь между МС и мерцанием предсердий, трепетанием предсердий, удлинением интервала QTc и увеличением дисперсии QTc, нарушением атриовентрикулярного проведения, дис-функцией синусового узла, снижением вариабельности ритма сердца, внезапной сердечной смертью [13, 14, 15, 16, 17].”
Enhancing Heart Rate Variability
Utzinger-Wheeler, M. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00078-9 · Cited by 1
Enhancing Heart Rate Variability
Utzinger-Wheeler, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00096-7 · Cited by 1
Sami, M. M., & Sana (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.466 · Cited by 1
Metadata
- Authors
- Liao, D., Sloan, R. P., Cascio, W. E., Folsom, A. R., Liese, A. D., Evans, G. W., Cai, J., & Sharrett, A. R.
- Affiliations
- Pennsylvania State University (US)
- University of Minnesota (US)
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- University of Münster (DE)
- Wake Forest University Health Sciences (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1998-12-01
- Volume
- 21
- Issue
- 12
- Pages
- 2116-2122
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1987379871
- Cited by
- 223
- References
- 0
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 11 · 2017: 3 · 2016: 3 · 2015: 15 · 2014: 9 · 2013: 17 · 2012: 12
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc55016-37-0-0, 5r01hl055669-04, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC55016, N01‐HC‐55015, 5R01 HL 55669)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart rate variability, cardiac autonomic control, hypertension, type 2 diabetes, dyslipidemia, fasting insulin, spectral power, cardiovascular risk
- MeSH terms
- Arteriosclerosis, Blood Pressure, Diabetes Mellitus, Type 2, Female, Heart Rate, Humans, Hyperlipidemias, Hypertension, Longitudinal Studies, Male, Middle Aged, Risk Factors, Syndrome, United States, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review